NCT00600600

Tigecycline for Treatment of Rapidly Growing Mycobacteria

Use of Tigecycline for Treatment of Serious Infection Due to Rapidly Growing Mycobacteria (Especially M.Abscessus)

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 8 (actual)
• Sponsor: The University of Texas Health Science Center at Tyler · Academic / Other
• Sex: All
• Age: 10 Years
• Healthy volunteers: Not accepted

Summary

To determine the safety, tolerance, and efficacy of Tigecycline when given daily to patients with rapidly growing mycobacterial disease (especially M.abscessus).

Detailed description

To assess the safety and efficacy of tigecycline in the treatment of drug resistant rapidly growing mycobacterial disease especially M. abscessus

Conditions

• Mycobacterium Abscessus Lung Disease
• Rapidly Growing Mycobacterial Lung Disease

Interventions

Type	Name	Description
DRUG	Tigecycline	Tigecycline dosage based on age and clinical status of patient.

Timeline

• Start date: 2002-04-01
• Primary completion: 2010-04-01
• Completion: 2010-12-01
• First posted: 2008-01-25
• Last updated: 2017-05-23

Locations

1 site across 1 country: United States